Advanced Medical Optics sells notes to buy back $500m in shares:
This article was originally published in Clinica
Advanced Medical Optics is intending to raise up to $500m through a sale of convertible senior subordinated notes due 2026. The Santa Ana, California-based ophthalmic company plans to use the net proceeds from the offering, together with borrowings under its senior credit facility, to purchase $500m worth of shares of its common stock, as well as up to $100m of its outstanding convertible notes. The move, viewed as an "extremely positive" proposal, is expected to have a significantly accretive impact on the firm's profits for 2006 and 2007, forecasts Merrill Lynch analyst Lee Brown.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.